Skip to content
OpenCapital
Get started

Nautilus Biotechnology, Inc. NAUT Q2 2026 earnings

Reported July 28, 2026 · Before market open

Revenue$190.0KBeat by $90.0K
EPS-$0.11Beat by $0.03
Revenue estimate$100.0K
EPS estimate-$0.14

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$190.0KBeat by $90.0K

Diluted EPS

Q2 2026-$0.11Beat by $0.03
Q1 2026-$0.12Beat by $0.02Q4 2025-$0.11Beat by $0.03Q3 2025-$0.11Beat by $0.04Q2 2025-$0.12Beat by $0.04Q1 2025-$0.13Beat by $0.01

Ask the moment Nautilus Biotechnology, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Nautilus Biotechnology, Inc. report Q2 2026 earnings?
Nautilus Biotechnology, Inc. (NAUT) reported Q2 2026 earnings on July 28, 2026 before market open.
What were Nautilus Biotechnology, Inc.'s Q2 2026 revenue and EPS?
Nautilus Biotechnology, Inc. reported revenue of $190.0K and eps of $-0.11 for Q2 2026.
Did Nautilus Biotechnology, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $100.0K by $90.0K. EPS beat the consensus estimate of $-0.14 by $0.03.
How did Nautilus Biotechnology, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 8.3% from $-0.12.
Where can I find Nautilus Biotechnology, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001808805-26-000030) and the 10-Q periodic report (0001808805-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.